- Report
- December 2025
- 168 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- November 2025
- 191 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- October 2025
- 188 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- February 2025
- 200 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- July 2024
- 120 Pages
Global
From €5243EUR$5,950USD£4,605GBP
- Report
- April 2023
- 119 Pages
Global
From €3965EUR$4,500USD£3,483GBP
- Report
- November 2025
- 132 Pages
Global
From €837EUR$950USD£735GBP
- Report
- November 2021
- 270 Pages
Global
From €2203EUR$2,500USD£1,935GBP
The Peptide Microarray market is a subset of the biotechnology industry that focuses on the development and production of peptide microarrays. These microarrays are used to detect and measure the presence of peptides in a sample, and are used in a variety of research and clinical applications. Peptide microarrays are used to identify biomarkers, measure drug efficacy, and study protein-protein interactions. They are also used to study the effects of post-translational modifications on protein function.
The Peptide Microarray market is highly competitive, with a number of companies offering products and services. Companies in the market include Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more
